Your browser doesn't support javascript.
loading
IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid.
Naujoks, Jan; Tabeling, Christoph; Dill, Brian D; Hoffmann, Christine; Brown, Andrew S; Kunze, Mareike; Kempa, Stefan; Peter, Andrea; Mollenkopf, Hans-Joachim; Dorhoi, Anca; Kershaw, Olivia; Gruber, Achim D; Sander, Leif E; Witzenrath, Martin; Herold, Susanne; Nerlich, Andreas; Hocke, Andreas C; van Driel, Ian; Suttorp, Norbert; Bedoui, Sammy; Hilbi, Hubert; Trost, Matthias; Opitz, Bastian.
Afiliação
  • Naujoks J; Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Tabeling C; Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Dill BD; MRC Protein Phosphorylation Unit, University of Dundee, Dundee, United Kingdom.
  • Hoffmann C; Max-von-Pettenkofer Institute, Ludwig Maximilian University, Munich, Germany.
  • Brown AS; The Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, Australia.
  • Kunze M; Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Kempa S; Integrative Metabolomics and Proteomics, Institute of Medical Systems Biology/Max-Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Peter A; Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Mollenkopf HJ; Max Planck Institute for Infection Biology, Berlin, Germany.
  • Dorhoi A; Max Planck Institute for Infection Biology, Berlin, Germany.
  • Kershaw O; Department of Veterinary Pathology, Free University Berlin, Berlin, Germany.
  • Gruber AD; Department of Veterinary Pathology, Free University Berlin, Berlin, Germany.
  • Sander LE; Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Witzenrath M; Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Herold S; Medizinische Klinik II, University Giessen and Marburg Lung Center, Justus-Liebig-University Giessen, Giessen, Germany.
  • Nerlich A; Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Hocke AC; Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • van Driel I; The Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, Australia.
  • Suttorp N; Department of Internal Medicine/Infectious Diseases and Pulmonary Medicine, Charité University Medicine Berlin, Berlin, Germany.
  • Bedoui S; The Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia.
  • Hilbi H; Max-von-Pettenkofer Institute, Ludwig Maximilian University, Munich, Germany.
  • Trost M; Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
  • Opitz B; MRC Protein Phosphorylation Unit, University of Dundee, Dundee, United Kingdom.
PLoS Pathog ; 12(2): e1005408, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26829557
Macrophages can be niches for bacterial pathogens or antibacterial effector cells depending on the pathogen and signals from the immune system. Here we show that type I and II IFNs are master regulators of gene expression during Legionella pneumophila infection, and activators of an alveolar macrophage-intrinsic immune response that restricts bacterial growth during pneumonia. Quantitative mass spectrometry revealed that both IFNs substantially modify Legionella-containing vacuoles, and comparative analyses reveal distinct subsets of transcriptionally and spatially IFN-regulated proteins. Immune-responsive gene (IRG)1 is induced by IFNs in mitochondria that closely associate with Legionella-containing vacuoles, and mediates production of itaconic acid. This metabolite is bactericidal against intravacuolar L. pneumophila as well as extracellular multidrug-resistant Gram-positive and -negative bacteria. Our study explores the overall role IFNs play in inducing substantial remodeling of bacterial vacuoles and in stimulating production of IRG1-derived itaconic acid which targets intravacuolar pathogens. IRG1 or its product itaconic acid might be therapeutically targetable to fight intracellular and drug-resistant bacteria.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença dos Legionários / Interferons / Macrófagos Alveolares / Legionella pneumophila / Proteoma / Hidroliases Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença dos Legionários / Interferons / Macrófagos Alveolares / Legionella pneumophila / Proteoma / Hidroliases Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos